Abstract
Cardiovascular complications arising from antineoplastic therapies have become an emerging public health issue due to the growing population of cancer survivors. Cardiotoxicity induced by chemotherapeutic agents commonly used to treat various neoplasms, such as doxorubicin (dox), is a severe condition that can progress to chronic cardiomyopathy, congestive heart failure, and patient death…